Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS – Get Free Report) was the recipient of a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 37,892 shares, an increase of 200.7% from the June 30th total of 12,601 shares. Based on an average daily trading volume, of 141,845 shares, the short-interest ratio is currently 0.3 days. Currently, 0.1% of the company’s stock are short sold.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Mercer Global Advisors Inc. ADV purchased a new stake in Neuberger Berman High Yield Strategies Fund during the 3rd quarter worth about $80,000. Integrity Advisory Solutions LLC acquired a new position in shares of Neuberger Berman High Yield Strategies Fund during the fourth quarter worth about $81,000. XTX Topco Ltd purchased a new stake in shares of Neuberger Berman High Yield Strategies Fund during the second quarter worth approximately $113,000. Kestra Advisory Services LLC increased its stake in shares of Neuberger Berman High Yield Strategies Fund by 18.0% during the fourth quarter. Kestra Advisory Services LLC now owns 18,728 shares of the investment management company’s stock worth $139,000 after buying an additional 2,857 shares during the period. Finally, CoreCap Advisors LLC acquired a new stake in Neuberger Berman High Yield Strategies Fund in the second quarter valued at approximately $119,000.
Neuberger Berman High Yield Strategies Fund Price Performance
Neuberger Berman High Yield Strategies Fund stock traded down $0.02 during mid-day trading on Tuesday, reaching $5.99. 207,470 shares of the company’s stock were exchanged, compared to its average volume of 235,962. Neuberger Berman High Yield Strategies Fund has a twelve month low of $5.98 and a twelve month high of $7.75. The company has a fifty day moving average of $6.22 and a 200-day moving average of $6.75.
Neuberger Berman High Yield Strategies Fund Dividend Announcement
About Neuberger Berman High Yield Strategies Fund
The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.
Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.
Read More
- Five stocks we like better than Neuberger Berman High Yield Strategies Fund
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Neuberger Berman High Yield Strategies Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuberger Berman High Yield Strategies Fund and related companies with MarketBeat.com's FREE daily email newsletter.
